J. Borrás-Blasco

发表

Influence of sodium lauryl sulphate on the in vitro percutaneous absorption of compounds with different lipophilicity

M. J. Morant, O. Díez‐Sales, J. Borrás-Blasco, 1997 .

Clinical and economic impact of the use of etanercept 25 mg once weekly in rheumatoid arthritis, psoriatic arthropathy and ankylosing spondylitis patients

J. Borrás-Blasco, A. Gracia-Pérez, J. Rosique-Robles, 2014, Expert opinion on biological therapy.

Probable Interaction between Citalopram and Acenocoumarol

J. Borrás-Blasco, A. Navarro-Ruiz, José Luis Marco-Garbayo, 2002, The Annals of pharmacotherapy.

The use of adalimumab, etanercept, golimumab and infliximab in rheumatic pathologies: variation between label dosage and real-world use

V. Escudero-Vilaplana, Jesús Mayorga-Pérez, J. Borrás-Blasco, 2015, Expert review of pharmacoeconomics & outcomes research.

Response to Ustekinumab in a Patient with Severe Psoriasis when Adalimumab Dose Escalation Fails

J. Borrás-Blasco, J. Rosique-Robles, F. Abad, 2014 .

Effectiveness of a systematic vaccination program in patients with autoimmune inflammatory disease treated with anti-TNF alpha drugs

J. Borrás-Blasco, X. Cortés, A. Gracia-Pérez, 2016, Expert opinion on biological therapy.

Acceptability of switching adalimumab from a prefilled syringe to an autoinjection pen

J. Borrás-Blasco, A. Gracia-Pérez, J. Rosique-Robles, 2010, Expert opinion on biological therapy.

Adverse Cutaneous Reactions Induced by TNF-&agr; Antagonist Therapy

C. Borrás, J. Borrás-Blasco, A. Navarro-Ruiz, 2009, Southern medical journal.

Economical impact associated with a biological therapy prioritization protocol in patients with rheumatoid arthritis in the Hospital of Sagunto

J. Borrás-Blasco, X. Cortés, J. Rosique-Robles, 2014, Expert opinion on biological therapy.

Oral and cutaneous lichenoid reaction secondary to imatinib: report of two cases

J. Borrás-Blasco, J. Pascual, J. Matarredona, 2006, International journal of dermatology.

Recombinant Factor VIIa is an Effective Therapy for Abdominal Surgery and Severe Thrombocytopenia: A Case Report

J. Borrás-Blasco, A. Navarro-Ruiz, A. Gómez, 2005, International journal of hematology.

Evaluation of once daily tobramycin dosing in critically ill patients through Bayesian simulation

J. Borrás-Blasco, J. Peris-Martí, J. Rosique-Robles, 2004, Journal of clinical pharmacy and therapeutics.

Skin permeation model of phenylalkylcarboxylic homologous acids and their enhancer effect on percutaneous penetration of 5-Fluorouracil

M. J. Morant, M. Herráez, O. Díez‐Sales, 1996 .

Early onset neutropenia after rituximab in lupus nephritis.

J. Borrás-Blasco, M. Masiá, R. Enríquez, 2007, Clinical and experimental rheumatology.

Dose modification of anti-TNF in rheumatoid arthritis and estimated economical impact: a review of observational studies

J. Borrás-Blasco, A. Navarro Ruiz, 2015, Expert review of pharmacoeconomics & outcomes research.

Burning Mouth Syndrome Due to Efavirenz Therapy

J. Borrás-Blasco, J. Rosique-Robles, M. E. Casterá, 2006, The Annals of pharmacotherapy.

Photo-Induced Stevens–Johnson Syndrome Due to Sulfasalazine Therapy

J. Borrás-Blasco, A. Navarro-Ruiz, J. Matarredona, 2003, The Annals of pharmacotherapy.

Adverse cutaneous reactions associated with the newest antiretroviral drugs in patients with human immunodeficiency virus infection.

C. Borrás, J. Borrás-Blasco, A. Navarro-Ruiz, 2008, The Journal of antimicrobial chemotherapy.

Hair Loss Induced by Lopinavir‐Ritonavir

J. Borrás-Blasco, A. Belda, E. Casterá, 2007, Pharmacotherapy.

Exacerbation of psoriatic skin lesions in a patient with psoriatic arthritis receiving adalimumab

J. Borrás-Blasco, A. Gracia-Pérez, J. Rosique-Robles, 2008, Journal of clinical pharmacy and therapeutics.

Erythrodermia induced by omeprazole.

J. Borrás-Blasco, A. Navarro-Ruiz, F. Navarro-Blasco, 2001, International journal of clinical pharmacology and therapeutics.

A mathematical approach to predicting the percutaneous absorption enhancing effect of sodium lauryl sulphate.

O. Díez‐Sales, J. Borrás-Blasco, M. Herráez-Domínguez, 2004, International journal of pharmaceutics.

Acute Seizures Due to a Probable Interaction between Valproic Acid and Meropenem

J. Borrás-Blasco, F. J. Coves-Orts, A. Murcia-López, 2005, The Annals of pharmacotherapy.

Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acid

J. Borrás-Blasco, S. Costa, E. Casterá, 2007, Journal of clinical pharmacy and therapeutics.

Hyperhidrosis related to nevirapine therapy

J. Borrás-Blasco, A. Belda, I. Jiménez, 2012, International journal of STD & AIDS.

Ciprofloxacin, but not levofloxacin, affects cyclosporine blood levels in a patient with pure red blood cell aplasia.

J. Borrás-Blasco, A. Navarro-Ruiz, Francisca Marín-Jimenez, 2005, The American journal of the medical sciences.

Unrecognized Delayed Toxic Lithium Peak Concentration in an Acute Poisoning with Sustained Release Lithium Product

J. Borrás-Blasco, A. Murcia-López, A. Navarro-Ruiz, 2007, Southern medical journal.

Legionella pneumophila pneumonia possibly due to ustekinumab therapy in a patient with Crohn's disease.

J. Borrás-Blasco, X. Cortés, S. Fernández-Martínez, 2017, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Septic shock and community-acquired pneumonia associated with etanercept therapy.

J. Borrás-Blasco, V. López-Camps, A. Gracia-Pérez, 2008, International journal of clinical pharmacology and therapeutics.

Educational session as a tool to increase patient satisfaction of switching etanercept from the prefilled syringe to the autoinjection pen

J. Borrás-Blasco, A. Gracia-Pérez, J. Rosique-Robles, 2013, Expert opinion on biological therapy.

Successful treatment of severe gastrointestinal bleeding secondary to Crohn disease with recombinant factor VIIa.

J. Borrás-Blasco, A. Navarro-Ruiz, M. García-Sepulcre, 2007, Southern medical journal.

Six months multicentre pilot open label single‐arm study to evaluate patient experience, acceptability and satisfaction of switching certolizumab pegol from a prefilled syringe or autoinjection pen to an AVA® e‐Device in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis patients

A. García-Monsalve, J. Borrás-Blasco, F. J. Rodríguez-Lucena, 2022, Journal of clinical pharmacy and therapeutics.

Ustekinumab therapy for Crohn's disease during pregnancy: a case report and review of the literature

J. Borrás-Blasco, X. Cortés, J. Moles, 2017, Journal of clinical pharmacy and therapeutics.

Urticaria due to etanercept in a patient with psoriatic arthritis.

J. Borrás-Blasco, A. Gracia-Pérez, J. Rosique-Robles, 2009, Southern medical journal.

Henoch-Schönlein purpura associated with clarithromycin. Case report and review of literature clarithromycin. Case report and review of literature

Joaquín Borrás-Blasco, R Enriquez, F Amorós, 2003 .

Acenocoumarol-Induced Henoch-Schönlein Purpura

J. Borrás-Blasco, A. Navarro-Ruiz, J. Matarredona, 2004, The Annals of pharmacotherapy.

Henoch-Schönlein purpura associated with clarithromycin. Case report and review of literature.

J. Borrás-Blasco, A. Navarro-Ruiz, J. Cabezuelo, 2003, International journal of clinical pharmacology and therapeutics.

Possible macular exanthema associated with linezolid therapy.

J. Borrás-Blasco, J. Verge, E. Casterá, 2006, International journal of clinical pharmacology and therapeutics.

Severe Stomatitis Complicating Treatment With Pegylated-Interferon α-2a and Ribavirin in an HCV-Infected Patient

J. Borrás-Blasco, J. Primo, J. Rosique-Robles, 2008, Southern medical journal.

Severe Myalgia Associated with Adalimumab Treatment in a Patient with Crohn's Disease

N. Maroto, J. Borrás-Blasco, R. Alós, 2008, The Annals of pharmacotherapy.

Safety of Ferric Carboxymaltose Immediately after Infliximab Administration, in a Single Session, in Inflammatory Bowel Disease Patients with Iron Deficiency: A Pilot Study

J. Borrás-Blasco, X. Cortés, J. Moles, 2015, PloS one.

Use of recombinant factor VIIa for life-threatening bleeding in a patient with severe necrotizing pancreatitis.

J. Borrás-Blasco, A. Navarro-Ruiz, F. Palacios-Ortega, 2005, Pancreas.

Unsuspected rhabdomyolysis associated with phenytoin.

J. Borrás-Blasco, A. Navarro-Ruiz, F. J. Santos-Calle, 2005, International journal of clinical pharmacology and therapeutics.

Optic Neuritis with Concurrent Etanercept and Isoniazid Therapy

J. Borrás-Blasco, A. Navarro-Ruiz, R. NogueraPons, 2005, The Annals of pharmacotherapy.

Cost-effectiveness analysis of ferric carboxymaltose versus iron sucrose for the treatment of iron deficiency anemia in patients with inflammatory bowel disease in Spain

W. Valentine, B. Hunt, F. Bermejo, 2022, Therapeutic advances in gastroenterology.

Humanization Guide of the Spanish Society of Hospital Pharmacy for patients with inflammatory immune-mediated diseases.

J. Borrás-Blasco, G. Mercadal-Orfila, A. Álvarez-Díaz, 2022, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Imipenem-induced Clostridium difficile diarrhea in a patient with chronic renal failure.

J. Borrás-Blasco, A. Navarro-Ruiz, S. Padilla, 2011, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

Successful desensitization protocol for hypersensitivity reactions caused by oxaliplatin.

J. Borrás-Blasco, E. Casterá, D. Rosique-Robles, 2007, International journal of clinical pharmacology and therapeutics.

Foot ischaemia and toe skin necrosis associated with interleukin-2 infusion in an HIV-infected patient

J. Borrás-Blasco, A. Belda, E. Casterá, 2009, International journal of STD & AIDS.

Alfuzosin-associated dermatomyositis.

J. Borrás-Blasco, A. Navarro-Ruiz, P. Vela-Casasempere, 1998, British journal of rheumatology.

Consensus of Spanish Society of Hospital Pharmacy on optimal medication therapy management of atopic dermatitis.

J. Borrás-Blasco, A. Navarro-Ruiz, E. R. Herráiz, 2023, Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria.

Emergency Clinical Trials

C. Borrás, J. Borrás-Blasco, A. Navarro-Ruiz, 2010 .

Persistence, Clinical and Economic Impact of Infliximab CT-P13 in Rheumatoid Arthritis, Psoriatic Arthropathy and Ankylosing Spondylitis Naïve and Switched Patients: After 5 Years of Follow-Up

J. Borrás-Blasco, E. Casterá, D. Rosique-Robles, 2022, Journal of Pharmacy and Nutrition Sciences.